𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Levodopa treatment in Parkinson's disease: How does it affect dysphagia management?

✍ Scribed by Nóbrega, Ana Caline; Pinho, Patrícia; Deiró, Michele; Argolo, Natalie

Book ID
125447060
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
151 KB
Volume
20
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Does levodopa affect metaiodobenzylguani
Does levodopa affect metaiodobenzylguanidine myocardial accumulation in Parkinson's disease?
✍ Masahiko Kishi; Ryuji Sakakibara; Hitoshi Terada; Emina Ogawa; Terada Tateno 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB

Mancozeb is a ethylene-bis-dithiocarbamate (EBDC) fungicide that contains zinc and manganese. 1 In humans, chronic EBDC inhalation has been associated with neurocognitive impairment and parkinsonism 2 while acute intoxication elicit reversible headache, dizziness, and seizures in a few cases, all of

Levodopa treatment does not affect low-d
Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease
✍ Svenja Happe; Tobias Tings; Kathrin Helmschmied; Karin Neubert; Wolfgang Wuttke; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

## Abstract Challenge with low‐dose apomorphine causes a significant rise in growth hormone (GH) in patients with Parkinson's disease (PD) compared to controls and patients with multiple system atrophy (MSA) who have not previously received dopaminergic treatment. To date, it has not been demonstra